Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2021-03-29 / Front Immunol 2021;12:641307Cell Therapies in Bladder Cancer Management
/in Dendritic Cells, International Publications, Urothelial Carcinoma /von 2021-03-10 / Int J Mol Sci 2021 Mar;22(6)A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2021-02-27 / Ann Surg Oncol 2021 Oct;28(11):6126-6137ASO Author Reflections: The Tumor Lysate, Particle-Loaded, Dendritic Cell Vaccine for Advanced-Stage Melanoma: Reflection on Personalized Cancer Vaccination
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2021-02-26 / Ann Surg Oncol 2021 10;28(11):6138-6139Therapeutic efficacy of dendritic cell vaccine combined with programmed death 1 inhibitor for hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2021-01-28 / J Gastroenterol Hepatol 2021 Jul;36(7):1988-1996Dendritic cell vaccine therapy for colorectal cancer
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2020-12-28 / Pharmacol Res 2021 Feb;164:105374Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged
/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2020-12-24 / Cancers (Basel) 2020 Dec;13(1)A Perspective on Cell Therapy and Cancer Vaccine in Biliary Tract Cancers (BTCs)
/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2020-11-17 / Cancers (Basel) 2020 Nov;12(11)High Health-Related Quality of Life During Dendritic Cell Vaccination Therapy in Patients With Castration-Resistant Prostate Cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2020-10-26 / Front Oncol 2020;10:536700
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de